BRAC |
Activity-Rest physiologic cycle |
BC |
Breast Cancer |
CTCs |
Circulating Tumor cells |
CSCs |
Cancer Stem Cells |
eBC |
Early Breast Cancer |
ECM |
Extracellular matrix |
EMT |
Epithelial Mesenchimal Transition |
ER |
Estrogen Receptor |
EOT |
End of Treatment |
HER2 |
Human Epidermal Growth Factor Receptor 2 |
HIF-1 |
Hipoxia-inducible factor 1 |
HPA |
Hypothalamic- pituitary-adrenal axis |
LIF |
Leukemia inhibitory factor |
MCP-3 |
Monocyte Chemotactic protein-3 |
MBT |
Mind Body Therapy |
MBT-T |
Mind-Body Transformations Therapy |
MSL |
Mesenchymal Stem-Like |
NFKB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
PDL1 |
Programmed Cell Death Ligand-1 |
RFS |
Relapse free survival |
PgR |
Progesteron Receptor |
RR |
Relaxation response (RR) |
SNS |
sympathetic nervous system (SNS) |
TNBC |
Triple Negative Breast Cancer |